HealSun Biopharm

Company Deals

Hangzhou HealSun Biopharm Secures RMB 200 Million in Series B+ Financing

Fineline Cube Oct 8, 2023

Hangzhou HealSun Biopharm Co., Ltd., a Chinese contract research organization (CRO) and contract development and...

Company Deals

Healsun Biopharm Raises USD 36.7 Million in Series B Financing for Antibody CDMO Expansion

Fineline Cube Aug 19, 2022

China-based Hangzhou Healsun Biopharm Co., Ltd, an antibody and recombinant Contract Development and Manufacturing Organization...

Company

Fosun Pharma Reports 2025 Results – Innovative Drug Revenue Surges 30% to RMB 9.9 Billion, Overseas Sales Hit RMB 13 Billion

Company Drug

Alphamab Oncology Doses First Patient in Phase III KN026 Study – Bispecific HER2 Antibody Targets Adjuvant Breast Cancer

Others

Gilead to Acquire Ouro Medicines for $2.175 Billion – Keymed Biosciences Secures $320 Million from CM336 TCE Deal

Company Drug

Shenzhen Salubris Wins NMPA Approval for SAL0150 – Oral Long-Acting Diabetes/Obesity Drug Targets Weekly Dosing Regimen